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274 CF experience for respiratory trainees in the UK
D. Nazareth1, M.J. Walshaw1. 1British Thoracic Society, CF Specialist Advisory
Group, London, United Kingdom
Objectives: Since more CF patients are surviving into adulthood, the UK respiratory
specialist training curriculum has been strengthened to reﬂect the need for an
increased awareness of this condition. However, because the curriculum is already
full we wished to assess whether the current training schemes in the UK can cope
with this increased need.
Method: We surveyed all 523 adult respiratory trainees in the UK, asking about
availability of CF experience and placement at recognised CF centres.
Results: There was a 78% response rate. 96% had access to a CF centre within their
training region and 55% would rotate through this during their training (placement
duration 3−6 months). Although 59% were routinely posted to a CF centre,
16% were required to make their own training arrangements and 5% felt that passing
the specialist written exit examination would be sufﬁcient to meet requirements.
Only 56% of those posted to a CF centre indicated that the post helped them
achieve curriculum requirements. As regards further training, 10% indicated that
they have a special interest in CF, but only 12 are currently gaining CF-speciﬁc
training. Overall, 66% wished further sub-specialty experience.
Conclusions: This survey highlights that a large proportion of trainees in the UK
have limited exposure to CF during their training, despite alterations to the training
curriculum. Further representations have been made to the training authorities to
reinforce the need for increased CF training.
275 Cumulative exposure to ionising radiation in adults with cystic
ﬁbrosis
D. Nazareth1, P. Milburn-McNulty1, J. Gallagher1, A. Nazir1, M.J. Ledson1,
J. Greenwood1, M.J. Walshaw1. 1Liverpool Adult CF Unit, Liverpool, United
Kingdom
Background: Now that most CF patients are expected to survive into their
5th decade, the cumulative exposure to potentially carcinogenic ionising radiation
is important. We looked at the amount of ionising radiation given to our CF adults
over an 18-month period.
Method: All ionising radiation studies were reviewed for their impact on manage-
ment. Radiation was calculated using standard reference doses and expressed as
milliSievert [mSv].
Results: See the table. The average radiation dose was 2.65mSv, with 32% of
studies changing management (but only 9% of chest X-rays). Those with more
severe disease had a greater cumulative dose which was more likely to alter
management.
Conclusion: CF patients receive signiﬁcant medical radiation each year, but most
impacts on their management. CFRD, DIOS and infection with transmissible
Pseudomonas are associated with greater levels, in keeping with the more sig-
niﬁcant disease burden in these individuals. Care should be taken when ordering
investigations associated with ionising radiation, to reduce the long term effects as
life expectancy increases.
Table: Radiation exposure in CF.
FEV1
% predicted,
mean [SD]
Radiation
dose (mSv),
mean
% impacting
care
All patients (n = 257) 76 [22] 2.65 32
CFRD (n = 101) 67 [21] 3.73 37
DIOS (n = 5) 88 [28] 9.14 44
Transmissible Pseudomonas (n = 107) 72 [22] 3.38 34
Other Pseudomonas (n = 78) 78 [26] 2.05 37
Burkholderia species (n = 18) 72 [16] 2.03 8
276 Current practice of HRCT scanning in a large UK CF centre with
good clinical outcomes
N.J. Rowbotham1,2, S.P. Conway1, K. Brownlee1, T. Lee1,2. 1Leeds General
Inﬁrmary, Leeds Regional Paediatric Cystic Fibrosis Centre, Leeds, United
Kingdom; 2University of Leeds, School of Medicine, Leeds, United Kingdom
Objectives: Leeds Regional Paediatric CF Centre is a large UK centre with clinical
outcomes (FEV1; BMI; Rate of chronic Pseudomonas infection) better than the
UK average (UK CF Trust Registry 2010 data). There are no clear guidelines on
when to HRCT scan in CF patients. We have assessed our current practice.
Methods: Retrospective data were collected on all 167 paediatric patients who were
receiving full care at the Leeds CF Centre in November 2011. Patient notes, the hos-
pital results server, and the patients’ electronic records were accessed to determine
which patients had had a chest HRCT scan, at what age and for what indication.
For those over 10 who had never had an HRCT scan lung function (FEV1) and
IV antibiotic treatments over the past ﬁve years were documented.
Results: Patient age ranged from 0 to 17 years (mean 8). 32% of patients had had
an HRCT scan, 50% of these by their tenth birthday. The mean age at ﬁrst scan was
9 years with two distinct peaks at the ages of 6 and 12 years. The most common
indication was persistent cough (24%), followed by persistent x-ray changes (17%).
Of those over 10 who had never had an HRCT scan the average FEV1 was 83%,
and 45% had less than one course of intravenous antibiotics per year.
Conclusions: In our centre 68% of children had not had an HRCT scan. They
had maintained on average an FEV1 % predicted >80% normal and had required
minimal IV antibiotic courses. Some CF centres request 2-yearly HRCT scans. Our
data suggest further research is needed to deﬁne the clinical beneﬁt of routine scans
before universal adoption, as the lifetime radiation risk given survival projections
for today’s children with CF cannot be discounted.
277 Health status of cystic ﬁbrosis patients in British Columbia (BC):
does proximity to clinic matter?
A.M. Gravelle1, S. Jenkins1, M. McIlwaine1, Y. Lillquist1, A.G.F. Davidson1,
C. Loong1, M. Chilvers1,2. 1B.C. Children’s Hospital, Cystic Fibrosis Clinic,
Vancouver, Canada; 2B.C. Children’s Hospital, Division of Pediatric Respiratory
Medicine, Vancouver, Canada
Background: BC spans 944,735 km2 with Cystic Fibrosis (CF) patients spread through-
out. This poses a huge challenge for patients to attend clinic and meet CF Canada
guidelines of a minimum of 4 reviews/year. To reduce this, outreach clinics are held
to improve provision of care. However, access to BCCH CF clinic on health status in
BC patients is unknown.
Aim: To evaluate if proximity to BCCH CF clinic impacts patient’s health status.
Methods: Patients were divided into either Lower Mainland (LM) or outside (OLM).
The latter was split into: Northern BC/Yukon; Interior; and Vancouver Island. Data
were collected on: location; age of diagnosis; FEV1; nutritional and bacterial status
and admissions. Mann–Whitney tests were performed.
Results: 131 patients were reviewed. No signiﬁcant difference was found for BMI,
FEV1, Pseudomonas status or admissions in children in LM or OLM, however the
latter were diagnosed later (Median age LM: 0.4 yrs, OLM: 1.1 yrs P< 0.05). Table 1
shows regional data. Patients furthest from clinic had signiﬁcant diagnostic delay,
Pseudomonas colonization and lower BMI.
Table 1. Health status by region of BC
Variable Lower Mainland
BC (N= 82)
Interior BC
(N= 26)
Northern BC
(N= 11)
Vancouver
Island
(N= 11)
Median distance to BCCH (km) 30 425 786 79
Median FEV1% 89.5 93 91.5 88
Median BMI 17.1 18.2 15.2* 16.4
Median age @ diagnosis (years) 0.4 1.6 2.8# 2.8
% Pseudomonas @ diagnosis 7.3 0 27.3* 9.0
% Pseudomonas colonized 21.9 36 27.3 18.2
*p< 0.05, #p= 0.1.
Conclusions: A possible trend for reduced health status with increasing distance from
clinic was observed. The study is limited by small numbers in the regional analysis.
No change in FEV1was seen in children, however the impact in adulthood is unknown.
